Saturday 17 October 2026
Export LNTH’s income statement to Excel — free account
Lantheus Holdings, Inc.
LNTH Healthcare Drug Manufacturers Specialty & Generic
Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024. In the quarter to June 2026, revenue grew 2.68%, EPS was flat, free cash flow grew 13.6% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years.
99.70
0.29
−0.29%
Follow LNTH
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
10.41 | 6.38 | 14.76 | 25.32 | 0.00 | 0.00 | 123.59 | 13.20 | 19.79 | 19.35 |
Piotroski F-Score |
6 | 6 | 6 | 4 | 3 | 5 | 7 | 7 | 5 | 5 |
P/S ratio |
0.94 | 2.36 | 1.74 | 2.30 | 2.15 | 4.59 | 3.71 | 3.32 | 4.04 | 2.91 |
Altman Z-Score |
0.86 | 2.13 | 2.09 | 2.77 | 1.51 | 3.03 | 3.38 | 5.32 | 6.67 | 4.25 |
P/FCF ratio |
5.37 | 20.35 | 14.23 | 13.71 | 186.20 | 33.85 | 13.08 | 12.08 | 12.82 | 12.69 |
Altman Z″-Score (non-manufacturers) |
(1.34) | 0.93 | 2.07 | 1.90 | 1.71 | 1.02 | 2.38 | 6.34 | 7.16 | 4.61 |
Beneish M-Score |
(2.87) | (1.15) | (2.62) | (3.02) | (1.68) | (2.83) | (2.79) | (2.08) | (2.97) | (2.23) |
P/Operating CF |
22.19 | 59.82 | 34.57 | 35.67 | 1,283.42 | 140.38 | 32.94 | 38.36 | 39.25 | 49.81 |
P/B ratio |
0.00 | 33.61 | 8.43 | 6.98 | 1.42 | 4.20 | 7.76 | 5.28 | 5.69 | 4.12 |
Price to Tangible BV |
0.00 | 0.00 | 12.96 | 7.45 | 9.18 | 35.62 | 49.10 | 7.15 | 7.16 | 35.23 |
EV/Sales |
1.69 | 2.94 | 2.19 | 2.59 | 2.56 | 4.76 | 3.86 | 3.21 | 3.81 | 3.05 |
EV/EBITDA |
6.68 | 13.45 | 9.43 | 13.64 | 42.17 | 0.00 | 42.32 | 9.69 | 11.11 | 12.20 |
EV/Operating CF |
10.28 | 17.79 | 12.28 | 11.21 | 53.00 | 37.58 | 12.82 | 13.62 | 10.73 | 12.05 |
EV/FCF |
9.66 | 25.34 | 17.86 | 15.44 | 221.58 | 35.17 | 13.62 | 11.66 | 12.10 | 13.28 |
Quick Ratio |
2.01 | 2.49 | 2.98 | 2.06 | 1.66 | 2.08 | 2.54 | 5.33 | 5.16 | 2.20 |
Current Ratio |
2.53 | 3.16 | 3.70 | 2.62 | 2.29 | 2.61 | 2.74 | 5.80 | 5.52 | 2.70 |
Net Debt/EBITDA |
2.97 | 2.65 | 1.92 | 1.53 | 6.73 | (4.27) | 1.67 | (0.35) | (0.66) | 0.55 |
Debt/Assets |
108.68% | 69.85% | 60.58% | 47.81% | 25.11% | 20.23% | 42.24% | 34.07% | 28.59% | 25.56% |
Debt/Equity |
(2.61) | 11.51 | 3.75 | 1.69 | 0.42 | 0.38 | 1.25 | 0.69 | 0.52 | 0.52 |
Asset Turnover |
1.21 | 1.04 | 0.83 | 0.82 | 0.53 | 0.49 | 0.86 | 0.87 | 0.84 | 0.73 |
Operating CF/Net income |
1.85 | 0.44 | 1.51 | 2.54 | (1.22) | (0.76) | 10.04 | 0.93 | 1.74 | 1.67 |
Capex/Depreciation |
0.16 | (0.79) | (1.26) | (1.54) | (0.50) | 0.09 | (0.34) | 0.80 | (0.90) | (0.48) |
Interest Coverage |
2.13 | 2.82 | 3.71 | 3.79 | (0.44) | (7.85) | 5.04 | 18.21 | 23.23 | 15.74 |
| (18.34%) | (296.51%) | 85.94% | 34.12% | (4.29%) | (14.57%) | 6.16% | 51.73% | 32.82% | 21.45% | |
| 10.74% | 38.57% | 9.84% | 7.49% | (2.11%) | (8.22%) | 2.57% | 21.98% | 17.21% | 11.10% | |
ROIC |
29.37% | 15.06% | 17.99% | 14.97% | (0.40%) | (7.03%) | 3.84% | 34.28% | 38.52% | 14.94% |
Return on Tangible Assets |
16.61% | 63.57% | 16.17% | 14.18% | (6.02%) | (27.20%) | 5.08% | 31.25% | 24.74% | 31.98% |
Average Days of Receivables |
44.52 | 44.34 | 46.51 | 45.74 | 58.07 | 76.69 | 83.30 | 80.04 | 78.39 | 88.56 |
Research and Development Expense of Revenue |
4.04% | 5.47% | 4.97% | 5.76% | 9.66% | 10.58% | 33.33% | 5.99% | 10.96% | 11.50% |
Selling, General and Administrative Expense of Revenue |
24.97% | 27.81% | 27.18% | 29.69% | 32.46% | 51.46% | 25.01% | 20.61% | 24.23% | 29.44% |
Intangible Assets out of Total Assets |
0.12 | 0.07 | 0.06 | 0.02 | 0.50 | 0.47 | 0.28 | 0.13 | 0.11 | 0.43 |
Share Based Compensation of Revenue |
0.84% | 1.79% | 2.54% | 3.60% | 4.15% | 3.75% | 3.13% | 3.90% | 4.98% | 5.55% |
Graham Net Nets |
(0.89) | (0.27) | (0.29) | (0.15) | (0.23) | (0.08) | (0.06) | 0.06 | 0.07 | (0.05) |
Graham Number |
0.00 | 6.80 | 6.66 | 7.32 | 0.00 | 0.00 | 7.76 | 35.85 | 39.99 | 35.35 |
Earnings Yield |
9.60% | 15.67% | 6.77% | 3.95% | (1.70%) | (3.63%) | 0.81% | 7.58% | 5.05% | 5.17% |
Free Cash Flow Yield |
18.64% | 4.91% | 7.03% | 7.29% | 0.54% | 2.95% | 7.64% | 8.28% | 7.80% | 7.88% |
Revenue per Share |
9.42 | 8.89 | 8.98 | 8.91 | 6.27 | 6.30 | 13.65 | 18.99 | 22.17 | 22.84 |
Operating CF per Share |
1.55 | 1.47 | 1.60 | 2.06 | 0.30 | 0.80 | 4.11 | 4.47 | 7.87 | 5.78 |
Capex per Share |
0.10 | (0.44) | (0.50) | (0.57) | (0.23) | 0.05 | (0.24) | 0.75 | (0.89) | (0.53) |
Free Cash Flow per Share |
1.65 | 1.03 | 1.10 | 1.50 | 0.07 | 0.85 | 3.87 | 5.22 | 6.98 | 5.25 |
Cash per Share |
1.60 | 2.05 | 2.97 | 2.38 | 1.47 | 1.46 | 6.07 | 10.45 | 13.19 | 5.32 |
Shareholders Equity per Share |
(3.32) | 0.62 | 1.86 | 2.94 | 9.50 | 6.88 | 6.53 | 11.95 | 15.72 | 16.15 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(3.32) | 0.62 | 1.86 | 2.94 | 9.50 | 6.88 | 6.53 | 11.95 | 15.72 | 16.15 |
Free Cash Flow |
52.85 | 38.47 | 42.06 | 58.32 | 3.92 | 57.60 | 265.23 | 356.54 | 482.89 | 354.05 |
Working Capital |
66.98 | 101.10 | 142.66 | 106.80 | 103.72 | 145.29 | 429.92 | 898.47 | 1,086.11 | 566.55 |
Capital Expenditures |
3.21 | (16.31) | (19.13) | (22.06) | (12.47) | 3.68 | (16.55) | 51.28 | (61.86) | (36.09) |
Net Current Asset Value |
(251.59) | (212.72) | (173.41) | (118.41) | (171.39) | (163.55) | (196.49) | 250.56 | 434.30 | (237.64) |
EV/EBIT |
9.02 | 18.80 | 11.65 | 17.44 | 0.00 | 0.00 | 99.81 | 11.40 | 12.79 | 15.13 |
Capex to Sales |
(0.01) | 0.05 | 0.06 | 0.06 | 0.04 | (0.01) | 0.02 | (0.04) | 0.04 | 0.02 |
Price to Operating Income |
5.01 | 15.10 | 9.28 | 15.48 | 0.00 | 0.00 | 95.88 | 11.81 | 13.55 | 14.45 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.21 | 0.22 | 0.14 | 0.12 | 0.21 | 0.37 | 0.40 | 0.44 | 0.39 | 0.46 |
Cash ROIC |
23.72% | 10.46% | 9.33% | 14.52% | 0.48% | 7.81% | 18.67% | 17.04% | 18.81% | 17.54% |
Accounts Receivable Turnover |
8.15 | 8.60 | 8.17 | 7.96 | 6.96 | 5.93 | 6.18 | 5.21 | 5.00 | 4.38 |
Accounts Payable Turnover |
10.72 | 9.30 | 9.51 | 9.44 | 11.50 | 12.81 | 17.09 | 19.01 | 14.41 | 15.48 |
Inventory Turnover |
9.87 | 7.74 | 5.70 | 5.55 | 6.18 | 6.70 | 10.01 | 11.80 | 8.26 | 9.04 |
Average Days of Payables |
42.13 | 37.66 | 38.90 | 39.37 | 29.62 | 31.94 | 21.24 | 25.62 | 23.12 | 26.12 |
Days of Inventory on Hand |
39.24 | 56.25 | 71.53 | 61.73 | 65.02 | 53.98 | 36.64 | 39.82 | 45.51 | 39.37 |
Average Receivables |
37.06 | 38.54 | 42.01 | 43.64 | 48.77 | 71.67 | 151.37 | 248.84 | 306.86 | 351.73 |
Average Payables |
15.30 | 18.20 | 17.71 | 18.28 | 17.45 | 18.54 | 20.68 | 30.88 | 37.87 | 38.73 |
Average Inventory |
16.63 | 21.86 | 29.55 | 31.10 | 32.46 | 35.44 | 35.30 | 49.75 | 66.03 | 66.35 |
Average Assets |
249.14 | 319.88 | 411.84 | 422.88 | 637.87 | 866.80 | 1,092.52 | 1,486.20 | 1,815.74 | 2,103.87 |
Average Common Equity |
(145.90) | (41.61) | 47.15 | 92.80 | 314.40 | 489.32 | 455.79 | 631.52 | 951.95 | 1,088.90 |
Columns are period end dates